Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases.

Journal article

Luchner M. et al, (2021), Pharmaceutics, 13

T cell phenotypes in COVID-19 - a living review

Journal article

Hanna SJ. et al, (2021), Oxford Open Immunology, 2

The role and uses of antibodies in COVID-19 infections: a living review

Journal article

Scourfield DO. et al, (2021), Oxford Open Immunology, 2

Mucosal immune responses in COVID19 - a living review.

Journal article

Pearson CF. et al, (2021), Oxf Open Immunol, 2

Technological Approaches for Improving Vaccination Compliance and Coverage.

Journal article

Lemoine C. et al, (2020), Vaccines, 8

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Journal article

Milicic A. et al, (2017), Scientific Reports, 7

Development of persistent gastrointestinal S. aureus carriage in mice

Journal article

Flaxman A. et al, (2017), Scientific Reports, 7

Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy

Journal article

Walters AA. et al, (2015), Journal of Pharmacy and Pharmacology, 67, 400 - 408

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

Journal article

Warimwe GM. et al, (2013), Virology Journal, 10

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity

Journal article

Reyes-Sandoval A. et al, (2012), Molecular Therapy, 20, 1633 - 1647

Load More